Controlled Release Drug Delivery Market Set to Reach $90 Billion by 2030
The controlled release drug delivery market is expected to reach $90 billion by 2030, driven…
Biotechnology
Panntherapi Advances Epilepsy Treatment with PTI5803 Clinical Trial
Panntherapi prepares for Phase IIa clinical trial of PTI5803 in patients with resistant epilepsy, accelerating…
PannTheraPi Advances Epilepsy Treatment with Upcoming Phase IIa Clinical Trial
PannTheraPi prepares to conduct its first Phase IIa clinical trial with PTI5803 in patients with…
Senator Gillibrand Advocates for $2.5M Grant to Boost Trudeau Institute’s Research Capabilities
New York Senator Kirsten Gillibrand is pushing for a $2.5 million grant to support the…
Corbion Proposes New Supervisory Board Appointment: Per Falholt to Join Ranks
Corbion announces proposal to appoint Per Falholt to the Supervisory Board, bringing extensive experience in…
Meatable Acquires Uncommon Bios, Expands Cultivated Meat Platform
Meatable, a leading cultivated meat company, has acquired Uncommon Bios, a biotech firm specializing in…
Debut Biotech Raises Funds to Revolutionize Skin Care with Cutting-Edge Technology
Debut Biotech, a pioneering biotechnology company, has successfully raised funds to transform the skin care…
Moderna’s Meteoric Rise and Fall: A Tale of Vaccine Success and Market Volatility
Moderna's COVID-19 vaccine success story takes a hit as share price plummets, raising questions about…
Exploring the Future of Human Senses: A Deep Dive into Emerging Technologies
Discover how emerging technologies are transforming the way we experience the world, from sensory enhancements…
Australian Biotech Firm Vaxxas Secures $90 Million Funding for Revolutionary Vaccine Technology
Vaxxas, an Australian biotech company, has raised $90 million in funding to advance its innovative…